I’ve said it many times before. I’m a slow learner. For several years I have read the news and reports about the latest theory that conditions like schizophrenia, bipolar, and depression are linked to the body’s autoimmune system producing a low grade inflammation of the gut and brain. I set this theory aside, figuring that by the time pharma produces a new medication with side effects, another theory will have taken hold.
Last night I was wide awake at 2 a.m., my thoughts pinballing their way as usual around my brain. I was trying to get back to sleep by practicing mindfulness techniques, when suddenly I had a eureka moment. Baby aspirin! Why not baby aspirin for schizophrenia? It’s an anti-inflammatory. I’ve been taking baby aspirin for the past three years to reduce the risk of inflammation leading to heart attack and stroke, but it never occurred to me to think that it might also be considered a possible treatment for schizophrenia.
This morning I did a bit of google research and discovered that, indeed, researchers have been on to this possibility for several years. If you “do the research” like I did (lol) you’ll see that some articles are quick to say that baby aspirin appears to be an effective “add on” to your normal intake of antipsychotics or antidepressants. Just an add on, not taken on its own. But it you dig a bit further, you’ll come across a different story – that some scientists hope that anti-inflammatory agents such as baby aspirin may eventually replace the need for prescription drugs.
From the website of a for-profit treatment center: “A number of studies in recent years have drawn connections between schizophrenia and the immune system and have suggested that anti-inflammatory medications may improve treatment of this illness. The immune system has been linked to various psychiatric disorders, and research has associated the HLA gene system in particular (a system that plays a controlling role in various aspects of the immune system) with schizophrenia.
The Dutch study looked at a range of the best of these studies—all double-blind, randomized controlled trials—in order to determine if there was strong evidence in favor of the use of anti-inflammatory medications in combination with antipsychotic drugs. They found that a number of anti-inflammatory agents improved the results of antipsychotic drugs for schizophrenic patients.”
From an article in The Daily Mail:
“As soon as the word depression is mentioned, we tend to think of a mental problem that may need treatment with antidepressant drugs, with all their risk of side-effects such as weight gain and loss of libido.
But what if it actually has a physical cause that could be treated with anti-inflammatory drugs such as aspirin and ibuprofen, or even antibiotics?
This is the fascinating possibility being explored by scientists at Cambridge University.”
“The Cambridge team’s hope is that by teasing out the link between inflammation and depression, they may be able to help prevent thousands of deaths among those who suffer from the mood disorder — and prevent people needlessly being on antidepressant drugs.